Accelerate Diagnostics, Inc.
- UEI
- H6FFVL332FE4
- CAGE
- 0T3P1
- Primary NAICS
- 325413 In-Vitro Diagnostic Substance Manufacturing
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Website
- acceleratediagnostics.com
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Life Sciences Tools & Services
- SIC code
- 38 Instruments & Related Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Rapid ID/AST system- STL VAMC | Veterans Integrated Service Network 15 | $28,196 | |
| BPA for instrumentation, reagents/test kits needed to perform ID/AST rapid analysis of positive blood cultures | Veterans Integrated Service Network 16 | $0 | |
| Rapid ID/AST system- STL VAMC | Veterans Integrated Service Network 15 | $57,585 | |
| Pheno test | Veterans Integrated Service Network 7 | $45,000 | |
| EO14042 - BPA for instrumentation, reagents/test kits needed to perform ID/AST rapid analysis of positive blood cultures | Veterans Integrated Service Network 16 | $0 |
About Accelerate Diagnostics, Inc.
Accelerate Diagnostics, Inc. is a for-profit corporate entity based in Tucson, Arizona, specializing in developing and manufacturing advanced in vitro diagnostic products and services for clinical microbiology laboratories. The company provides rapid bacterial identification and antimicrobial susceptibility testing systems primarily to federal healthcare agencies, with a significant focus on delivering diagnostic solutions to the Department of Veterans Affairs (VA) and Department of Defense. Its core technological offering is the Accelerate Pheno system, which enables rapid identification of pathogens and determination of appropriate antibiotic treatments, supporting prompt and targeted medical interventions.
Through federal contract awards, Accelerate Diagnostics has consistently supplied diagnostic instrumentation, reagents, test kits, and quality control systems to multiple VA Veterans Integrated Service Networks (VISNs), including VISN 7, 10, 15, and 16. These contracts, predominantly non-set-aside awards, range from purchase orders to Blanket Purchase Agreements (BPAs) with values between $11,700 and $427,348. The company's primary contract deliverables include the Accelerate Pheno system, blood culture kits, antimicrobial susceptibility testing modules, and associated quality control tests. These products support VA medical centers in rapidly analyzing positive blood cultures, identifying pathogens, and determining appropriate antibiotic treatments for veterans.
Accelerate Diagnostics has received federal grant sub-awards focused on advancing diagnostic technologies to combat antimicrobial resistance. These grants, including awards from CARB-X and collaborations with institutions like Denver Health and Hospital Authority and Trustees of Boston University, support research into novel optical imaging techniques for microbe identification. The grant projects aim to develop more sensitive and specific methods for pathogen detection, with potential to dramatically reduce diagnostic times, minimize patient treatment delays, and address the growing threat of antimicrobial resistance through more precise diagnostic capabilities.
The company holds a significant federal contract Indefinite Delivery Vehicle (IDV) with the Department of Veterans Affairs, specifically a Blanket Purchase Agreement (BPA) with VISN 15 valued at $286,930. This single-award BPA, running through May 2, 2028, supports the procurement of a Rapid ID/AST system for the St. Louis VA Medical Center. The IDV enables the VA to acquire diagnostic products that support rapid pathogen identification and antibiotic susceptibility testing, ultimately aiming to improve clinical outcomes by allowing clinicians to prescribe targeted antibiotic therapies more quickly and efficiently.
Contract vehicles
Quick answers
What is Accelerate Diagnostics, Inc.'s UEI?
Accelerate Diagnostics, Inc.'s Unique Entity ID (UEI) in SAM.gov is H6FFVL332FE4.
What is Accelerate Diagnostics, Inc.'s CAGE code?
Accelerate Diagnostics, Inc.'s CAGE code is 0T3P1.
What is Accelerate Diagnostics, Inc.'s primary NAICS code?
Accelerate Diagnostics, Inc.'s primary NAICS code is 325413 (In-Vitro Diagnostic Substance Manufacturing).
Is Accelerate Diagnostics, Inc. registered in SAM.gov?
Accelerate Diagnostics, Inc.'s SAM.gov registration expired on February 10, 2026.
Which contract vehicles does Accelerate Diagnostics, Inc. hold?
Accelerate Diagnostics, Inc. holds a place on 1 federal contract vehicle: FSS-65-VII.
What is Accelerate Diagnostics, Inc.'s most recent federal award?
Accelerate Diagnostics, Inc.'s most recent federal contract award is Rapid ID/AST system- STL VAMC (36C25525N0230), from Veterans Integrated Service Network 15, on May 3, 2025.
On GovTribe
See Accelerate Diagnostics, Inc.'s full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors